• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Strong product sales lift Amgen’s Q1 earnings above street view

anonymous

Guest
Amgen reported an increase in first quarter earnings, driven by broad-based growth in product sales. Both earnings and sales topped street estimates.
Earnings rose 16% year-over-year to $3.25 per share during the quarter. Besides higher product sales, the growth was also driven by a decline in the tax rate. On an adjusted basis, profit advanced 10% to $3.47 per share.
At $5.6 billion, revenues were higher by 2% compared to the first quarter of 2017. The topline benefited from a double-digit increase in sales across all products.
https://news.alphastreet.com/strong...ns-q1-earnings-above-street-view-shares-gain/
 

<